BIOVITAE ’s Post

Those conversation about sustainability in the pharma industry are so important to have. If this is of interest to you, I'd love to have a chat! #sustainability

🌱 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗔𝗹𝗲𝗿𝘁! 𝗕𝗼𝗿𝗺𝗶𝗼𝗹𝗶 𝗣𝗵𝗮𝗿𝗺𝗮 𝗵𝗮𝘀 𝗷𝘂𝘀𝘁 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝗱 𝗶𝘁𝘀 𝘁𝗵𝗶𝗿𝗱 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗥𝗲𝗽𝗼𝗿𝘁, 𝘀𝗵𝗼𝘄𝗰𝗮𝘀𝗶𝗻𝗴 𝗶𝗺𝗽𝗿𝗲𝘀𝘀𝗶𝘃𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗶𝗻 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹, 𝘀𝗼𝗰𝗶𝗮𝗹, 𝗮𝗻𝗱 𝗴𝗼𝘃𝗲𝗿𝗻𝗮𝗻𝗰𝗲 (𝗘𝗦𝗚) 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲𝘀. 𝗔 𝘀𝘁𝗮𝗻𝗱𝗼𝘂𝘁 𝗮𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁: Bormioli Pharma reached 45% sustainable materials in its EcoPositive range, edging closer to its 50% target by 2025. CEO Andrea Lodetti emphasized the company's role in driving responsible growth within the pharmaceutical industry, highlighting initiatives supporting sustainable medical practices and EU goals for sustainable packaging. For more on Bormioli Pharma's sustainability journey, check out the full article on our website. #Sustainability #ESG #PharmaIndustry

New Year, New Horizons! I am thrilled to share that Lactocore is kicking off the year with a burst of activity. We're in San Francisco to participate in two major conferences, marking a promising start to what I believe will be a landmark year for us. The conferences are not just platforms for us to showcase our latest innovations, but also fertile grounds for nurturing new partnerships and collaborations. Our presence there is a testament to our commitment to stay at the forefront of biotechnological advancements and to keep pushing the boundaries in our field. 2024 is shaping up to be a year of significant growth in our sector. Market trends suggest a substantial increase in investment volumes, reflecting growing confidence in biotechnology's potential to revolutionize healthcare. Lactocore is positioned at the heart of this evolution, harnessing the power of peptides in groundbreaking ways. We are also witnessing an unprecedented level of partnering activity. The collaborative spirit in the industry is stronger than ever, and we are excited about the new synergies that will emerge. These partnerships are vital, as they combine diverse expertise and resources, driving innovation and progress. As I look ahead, I am filled with hope and determination. This year is about taking bold steps, embracing new challenges, and forging new paths. We at Lactocore are ready to rise to these opportunities, driven by our passion for science and our commitment to making a tangible difference in people's lives. Here's to a transformative and successful 2024! #Biotechnology #Innovation #Healthcare #NewYear2024 #Lactocore

The three pillars of circularity, wellbeing, and biosphere are interconnected principles that guide the transition towards a circular economy. They provide a framework for achieving a sustainable economic system that is resilient, good for business, people, and the environment, and capable of regenerating natural resources. #chiesi

35 million euros for sustainable biotechnology: An international consortium consisting of Evonik's venture capital unit, BOLD, the venture capital fund of L'Oréal and DTCF | DeepTech & Climate Fonds as well as Clay Capital fka VisVires New Protein, ICOS Capital and LIBERSET has invested in Abolis Biotechnologies. The French company develops customized solutions based on microorganisms to support the industry on its way to more sustainability. Abolis will use the funding to accelerate the research and development of innovative biomanufacturing and microbiome solutions. Evonik - with its Care Solutions Business Line - as well as L'Oréal and Abolis also agreed on a new industrial partnership. Together, they want to bring selected innovations for the health and cosmetics sectors and the chemical industry to market. More details at our media site: https://ow.ly/zyTp50Tl3EJ #Evonik #EvonikVentureCapital #Biotechnology #CareSolutions

At Novartis, championing Green Operations and fostering environmental sustainability are embedded in our DNA.   Our vision encompasses becoming a net-zero, plastic-neutral, and water-sustainable company. As a leading innovative medicines company, we have the size, scale, and reach to be a catalyst for positive change.    By integrating sustainable practices into our operations, we're not only reducing our carbon footprint but also leading the way towards a greener future.   Watch this video that outlines our commitment towards creating long term value for Novartis and mostly for our future generations.   #novartis #sustainability #operationalexcellence #gogreen #greenoperations Deepak Bisht Roland Gander Sergio Cerdas Petra Stefanic Anderluh Rupinder Arora Xavier Casals Jana Petek Alan Dy Vicky Véronneau Naveen Gullapalli Bernd Bucher Jan Hansen Heiko Potgeter Christoph Buerki Christina Madersbacher Nils Kjærgaard Mythili Mamidanna Jela Zdolsek  

🚨 Big Breakthrough in Biotechnology! 🚨 Helaina, a NYC-based biotech company, just secured $45M in Series B funding, bringing their total raised to $83M! 💼💰 This round was led by Avidity Partners, with additional investment from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity and Primary Venture Partners, among other strategic partners. The funding will fuel the scaling of their groundbreaking product, effera™ Human Lactoferrin, a novel ingredient supporting women’s health, active nutrition, and healthy aging. 🌱 💡 Why it matters: Helaina, under the leadership of CEO and Founder Laura Katz, is revolutionizing nutrition with human equivalent bioactive proteins. Using their precision fermentation platform, they’re bringing cutting-edge nutrition solutions to consumer brands and distribution partners. 🌍 What’s next? Helaina’s effera™ will soon be available in products from brands like Kroma Wellness, The Feed, and Levelle Nutrition, with Mitsubishi International Food Ingredients, Inc. as a key distribution partner. The future of health and nutrition just got a lot brighter! 🌟 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #Biotech #SeriesB #Innovation #HealthTech #Nutrition #Helaina #FutureTechly

For 50 years, from the origins of Fameccanica to the present day as Angelini Technologies, our journey has been closely tied to #Converting technology, an essential sector of industrial production. We have become pioneers and leaders in the consumer goods market, constantly investing in research and development and integrating different capabilities to set new records and develop even faster machines. Watch the video to explore the wide range of expertise we offer 👇 #AngeliniTechnologies #Fameccanica #AngeliniIndustries #InnovationInspiredByLife

The Biocat, BioRegion of Catalonia 2023 report presented today highlights the importance of public-private collaboration where the #BioRegio2023 is a benchmark in Europe. AstraZeneca is a key piece in this success story, betting on #Barcelona with an innovation global Hub that represents an investiment of 800 million euros and a thousand jobs in the next years. #healthinnovation #BioRegio23

Early Bird rates for Bio€quity Europe ends Friday - register now to save! With 60+ biotechs already confirmed to present, this year’s event in San Sebastián is expected to sell out, again. In fact, we are on track to exceed last year, when 300 VCs, 330 CEOs, and 150 C-level executives joined. This year we will gather in Basque Country to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. I hope you will join BioCentury Inc., EBD Group, and Regional Host Committee Chair Ysios Capital in one of the culinary capitals of the world. Register for #BioEquityEurope by Friday to save: https://ow.ly/lkOl50QyYeS Learn more, including the schedule-at-a-glance and presenting companies you will meet: https://ow.ly/8B5c50QyYeR #biotech #biopharma